
Welcure Drugs & Pharmaceuticals Share Price
₹8.44 +0.16 (1.93%)
09 Mar, 2025 13:20
Start SIP in
WELCURE
Performance
- Low
- ₹0
- High
- ₹0
- 52 Week Low
- ₹0
- 52 Week High
- ₹0
- Open Price₹0
- Previous Close₹0
- Volume
Investment Returns
- Over 1 Month -18.14%
- Over 3 Month + 4.58%
- Over 6 Month + 15.14%
- Over 1 Year + 87.97%
Smart Investing Starts Here Start SIP with Welcure Drugs & Pharmaceuticals for Steady Growth!
Welcure Drugs & Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
Welcure Drugs & Pharmaceuticals Financials
Welcure Drugs & Pharmaceuticals Technicals
EMA & SMA
Current Price
₹8.44
+
0.16
(1.93%)

-
- Bearish Moving Average 5
-
- Bullish Moving Average 11
- 20 Day
- ₹8.18
- 50 Day
- ₹8.87
- 100 Day
- ₹8.54
- 200 Day
- ₹7.43
Resistance and Support
8.44
- R3 8.44
- R2 8.44
- R1 8.44
- S1 8.44
- S2 8.44
- S3 8.44
Welcure Drugs & Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
Date | Purpose | Remarks |
---|---|---|
2025-02-14 | Quarterly Results | |
2024-11-14 | Quarterly Results | (Revised) |
2024-10-21 | Others | |
2024-08-14 | Quarterly Results | |
2024-06-10 | Others | Inter alia, 1. To augment of financial resources of the company, 2. To increase in authorised share capital of the company and 3. To shift branch office of the company. |
Welcure Drugs & Pharmaceuticals F&O
About Welcure Drugs & Pharmaceuticals
- NSE Symbol
- WELCURE
- BSE Symbol
- 524661
- Managing Director & CFO
- Mr. Altaf Hussain Shah
- ISIN
- INE331C01017
Similar Stocks to Welcure Drugs & Pharmaceuticals
Welcure Drugs & Pharmaceuticals FAQs
Welcure Drugs & Pharmaceuticals share price is ₹8 As on 09 March, 2025 | 13:06
The Market Cap of Welcure Drugs & Pharmaceuticals is ₹95 Cr As on 09 March, 2025 | 13:06
The P/E ratio of Welcure Drugs & Pharmaceuticals is 50.3 As on 09 March, 2025 | 13:06
The PB ratio of Welcure Drugs & Pharmaceuticals is 0.9 As on 09 March, 2025 | 13:06
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.